Grifols

Grifols is a global healthcare company dedicated to improving the health and well-being of people around the world. Founded in 1940, Grifols has established itself as a leader in the pharmaceutical and biotechnology sectors, focusing on the development of life-saving therapies derived from human plasma.

The company operates through three main divisions: Bioscience, Diagnostic, and Hospital. In the Bioscience division, Grifols produces a wide range of plasma-derived medicines that treat various chronic and acute conditions, including immune deficiencies and bleeding disorders.

In the Diagnostic division, Grifols offers innovative solutions for blood and plasma testing, ensuring safety and efficiency in transfusion medicine. The Hospital division provides essential products and services that enhance patient care in hospital settings.

Grifols is committed to research and development, investing significantly in innovation to advance medical science and improve patient outcomes. The company’s vision is to be a trusted partner in healthcare, providing high-quality products and services that meet the needs of patients and healthcare professionals alike.

With a presence in over 30 countries and a workforce of more than 24,000 employees, Grifols is dedicated to fostering a culture of collaboration and excellence. The company prioritizes sustainability and ethical practices, striving to make a positive impact on society and the environment.

Grifols is also actively involved in various community initiatives, supporting education, health, and social welfare programs. Through its commitment to corporate social responsibility, Grifols aims to contribute to a healthier future for all.